New York, NY - (ACCESSWIRE) - 11/06/2013 - Growing Stock Report initiates its NASDAQ Active Stock Watch List adding Myriad Genetics Inc. (NASDAQ:MYGN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Durata Therapeutics, Inc. (NASDAQ:DRTX), and Albany Molecular Research Inc. (NASDAQ:AMRI)
Myriad Genetics Inc. (NASDAQ:MYGN) a molecular diagnostic company that focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States closed down in its previous session (-0.75%) on 2,115,075 shares traded after Myriad Genetics Reported its Financial Results for First Quarter of Fiscal Year 2014. Myriad Genetics Inc. (NASDAQ:MYGN) is currently down (-34.41%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Myriad Genetics Inc. (NASDAQ:MYGN)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=MYGN&SubId=AW
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) a biopharmaceutical company that engages in the development of therapeutic products in the United States closed down in its previous session (-0.74%) on 1,650,049 shares traded. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is currently down (-24.75%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=NPSP&SubId=AW
Durata Therapeutics, Inc. (NASDAQ:DRTX) a pharmaceutical company that focuses on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses closed up in its previous session (+3.85%) on 95,240 shares traded after Durata Therapeutics Announced to Report its Third Quarter 2013 Financial Results Today. Durata Therapeutics, Inc. (NASDAQ:DRTX) is currently up (+51.13%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Durata Therapeutics, Inc. (NASDAQ:DRTX)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=DRTX&SubId=AW
Albany Molecular Research Inc. (NASDAQ:AMRI) a contract research and manufacturing organization, offers drug discovery, development, and manufacturing services to pharmaceutical and biotechnology companies in the United States, Europe, and Asia closed up in its previous session (+4.89%) on 267,007 shares traded after AMRI Announced Lifting of FDA Warning Letter Related to Burlington, Mass. Facility. Albany Molecular Research Inc. (NASDAQ:AMRI) is currently up (+295.51%) from its recent 52-week low, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Albany Molecular Research Inc. (NASDAQ:AMRI)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=AMRI&SubId=AW
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:
Growing Stock Report
editor@GrowingStockReport.com